-
Mashup Score: 144
AbstractAims. The ability of sodium–glucose co-transporter 2 (SGLT2) inhibitors to prevent atrial fibrillation (AF) has been evaluated in various studies w
Source: academic.oup.comCategories: General Medicine NewsTweet
AbstractAims. The ability of sodium–glucose co-transporter 2 (SGLT2) inhibitors to prevent atrial fibrillation (AF) has been evaluated in various studies w
💡 Can SGLT2 inhibitors prevent #AFib across different cardiovascular conditions? Read a new meta-analysis of RCTs just published in #EHJPharmacotherapy 🔍📝 https://t.co/6xNA9DOdl3 @EditorEHJCVP @FeliceGragnano @pizzi_carmine https://t.co/DmmLDkQOHa